Biochemical markers such as CA-125 were elevated in only 30 (31.25%) of our cases, predominantly in mixed tumours, a finding comparable with Kim et al. who cautioned against over-reliance on CA-125 in complex benign tumours [11]. Here, MUC16 is linked to benign neoplasm.